Obstructive sleep apnea and its relation to hypertension syndrome. Current evidence;Síndrome da apnéia obstrutiva do sono e sua relação com a hipertensão arterial sistêmica. Evidências atuais

Arquivos Brasileiros de Cardiologia

Volumn 78, Issue 5, 2002, Pages 531-536

  Drager, Luciano Ferreira ^a   Ladeira, Renata Teixeira ^a   Brandão Neto, Rodrigo Antônio ^a   Lorenzi Filho, Geraldo ^a   Benseñor, Isabela Martins ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SLEEP APNEA SYNDROME;

HUMANS; HYPERTENSION; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 0036581057     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2002000500013     Document Type: Article

References (83)

1. Victor LD. Obstructive sleep apnea. Am Fam Physician 1999; 60: 2279-86.
2. McNamara SG, Grunstein RR, Sullivan CE. Obstructive sleep apnea. Thorax 1993; 48: 754-64.
3. Dealberto MJ, Ferber C, Garma L, Lemoine P, Alperovitch A. Factors related to sleep apnea syndrome in sleep clinic patients. Chest 1994; 105: 1753-8.
4. Coleman J. Overview of sleep disorders. Where does obstructive sleep apnea syndrome fit in? Otolaryngol Clin North Am 1999; 32: 187-93.
5. Obstructive sleep apnea. In: Fraser RS, Müller NL, Colman N, Paré PD, eds, Diagnosis of Diseases of the Chest. Philadelphia: W. B. Saunders. 1999; 2054-76.
6. Young T, Palta M, Dempesey J, Skatrud J, Weber S, Badr S. The occurrence of sleepdisordered breathing among middle-aged adults. N Eng J Med 1993; 328: 1230-5.
7. Young T, Peppard P, Palta M, et al. Population-based study of sleepdisordered breathing as a risk factor for hypertension. Arch Intern Med 1997; 157: 1746-52.
8. Ancoli-Israel S, Kripke DF, Klauber MR, Mason WJ, Fell R, Kaplan O. Sleep-disordered breathing in community-dwelling elderly. Sleep 1991; 14: 486-95.
9. Cirignotta F, d' Alessandro R, Partinen M, et al. Prevalence of every night snoring and obstructive sleep apneas among 30-69 men in Bologna, Italy. Acta Neurol Scand 1989; 79: 366-72.
10. Bearpack H, Elliot L, Cullen S, et al. Home monitoring demonstrates high prevalence of sleep disordered breathing in men in the Busselton population. Sleep Res 1991; 20A: 411.
11. Martinez D, Foppa M, Silva GC, Canals AA, Caramori C, Caleffi L. Sintomas respiratórios associados a distúrbios do sono em trabalhadores industriais do Rio Grande do Sul. J Pneumol 1994; 20: 127-32.
12. Redline S, Stohl KP. Recognition and consequences of obstructive sleep apnea hypopnea syndrome. Clin Chest Med 1998; 19: 1-19.
13. Rosen R, Mahowald M, Chesson A, et al. The Task-Force 2,000 survey on medical education in sleep and sleep disorders. Sleep 1998; 21: 235-8.
14. Young T, Blustein J, Finn L, Palta M. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep 1997; 20: 705-6.
15. Weiss JW, Launois SH, Anand A, Garpestad E. Cardiovascular morbidity in obstructive sleep apnea. Prog Cardiov Dis 1999; 41: 367-76.
16. Silverberg DS, Oksenberg A, Iaina A. Sleep related breathing disorders are common contributing factors to the production of essential hypertension but are neglected, underdiagnosed, and undertreated. Am J Hypertens 1997; 10: 1319-25.
17. Portaluppi F, Provini F, Cortelli P, et al. Undiagnosed sleep-disordered breathing among male nondippers with essential hypertension. J Hypertens 1997; 15: 1227-33.
18. Pankow W, Nabe B, Lies A, et al. Influence of sleep apnea on 24-hour blood pressure. Chest 1997; 112: 1253-8.
19. George CFP. Diagnostic techniques in obstructive sleep apnea. Prog Cardiov Dis 1999; 41: 355-66.
20. Systematic review of the literature regarding the diagnosis of sleep apnea. Evid Rep Technol Assess (Summ) 1999; (1): i-viii, 1-154.
21. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KR. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999; 131: 485-91.
22. Sériès F, Marc D, Cormier Y, et al. Utility of nocturnal home oximetry for case finding in patients with suspected sleep apnea hypopnea syndrome. Ann Intern Med 1993; 119: 449-53.
23. Whittle AT, Finch SP, Mortimore IL, et al. Use of home sleep studies for diagnosis of the sleep apnea/hypopnea syndrome. Thorax 1997; 52, 1068-73.
24. Chervin RD, Guilleminault C. Obstructive sleep apnea and related disorders. Neurol Clin 1996; 14: 583-609.
25. Strollo PJ Jr, Rogers RM. Obstructive sleep apnea. N Engl J Med 1996; 334: 99-104.
26. Hla KM, Young TB, Bidwell T, et al. Sleep Apnea and Hypertension: a population based Study. Ann Intern Med, 1994; 120: 382-8.
27. Peppard P, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-84.
28. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. Br Med J 2000; 320: 479-82.
29. Fletcher EC. The relationship between systemic hypertension and obstructive sleep apnea: facts and theories. Am J Med 1995; 98: 118-28.
30. Nieto FJ, Young T, Lind B, et al. Sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 2000; 283: 1829-36.
31. Quan SF, Howard BV, Iber C, et al. The Sleep Heart Health Study: design, rationale, and methods. Sleep, 1997; 20: 1077-85.
32. Worsnop CJ, Naughton MT, Barter CE, Morgan TO, Anderson, Pierce RJ. The prevalence of obstructive sleep apnea in hypertensives. Am J Resp Crit Care Med 1998; 157: 111-5.
33. Hung J, Whitford EG, Parsons RW, Hillman DR. Association of sleep apnoea with myocardial infarction in men. Lancet 1990; 336: 261-4.
34. Javaheri S, Parker TJ, Wexler L, et al. Occult sleep-disordered breathing in stable congestive heart failure. Ann Intern Med 1995; 122: 487-92.
35. Sheppard JW. Hypertension, cardiac arrhythmias, myocardial infarction, and stroke in relation to obstructive sleep apnea. Clin Chest Med 1992; 13: 437-58.
36. Bassetti C, Aldrich MS, Chevin RD, Quint D. Sleep apnea in patients with transient ischemic attack and stroke: a prospective study of 59 patients. Neurology 1996; 47: 1167-73.
37. Qureshi AI, Giles WH, Croft JB, et al. Habitual sleep patterns and risk for stroke and coronary heart disease: a 10 year follow-up from NHAMES I. Neurology 1997; 48: 904-11.
38. Young T, Blustein J, Finn L, Palta M. Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults. Sleep 1997; 20: 608-13.
39. Thán JT, Gómez AJ, Guevara JC. The association between sleep apnea and the risk of traffic accidents. N Eng J Med 1999; 340: 847-51.
40. Carlson JT, Hedner J, Sellgren J, Elam M, Wallin BG. Augmented resting sympahetic activity in awake patients with obstructive sleep apnea. Chest 1993; 103:1763-8.
41. Carlson JT, Hedner J, Elam M, Sellgren J, Wallin BG. Depressed baroreflex sensitivity in patients with obstructive sleep apnea. Am J Resp Crit Care Med 1996; 154: 1490-6.
42. Hedner JA, Wilcox I, Laks L, Grunstein RR, Sullivan CE. A specific and potent effect of hypoxia in patients with sleep apnea. Am Rev Respir Dis 1992; 146: 1240-5.
43. Rodestein DO, D'Odemont JP, Pieters T, Aubert-Tulkens G. Diurnal and nocturnal diuresis and natriuresis in obstructive sleep apnea. Am Rev Respir Dis 1992; 145: 1367-71.
44. Coleman J. Complications of snoring, upper airway resistance syndrome, and obstructive sleep apnea syndrome in adults. Otolaryngol Clin North Am 1999; 32: 223-34.
45. American Thoracic Society: Sleep apnea, sleepnees, and driving risks. Am J Resp Crit Care Med 1994; 150: 1463-73.
46. García Río F, Racionero MA, Pino JM, et al. Sleep apnea and hypertension. Chest 2000; 117: 1417-25.
47. Noda A, Yasuma F, Okada T, Yokota M. Circadian rhythm of autonomic activity in patients with obstructive sleep apnea syndrome. Clin Cardiol 1998; 21: 4, 271-6.
48. Brooks D, Horner RL, Kozar LF, et al. Obstructive sleep apnea as a cause of systemic hypertension: evidence from a canine model. J Clin Invest 1997; 99: 106-9.
49. Koskenvuo M, Sarna S, Partinen M, et al. Snoring as a risk factor for hypertension and angina pectoris. Lancet 1985; 1: 863-6.
50. Millman RP, Redline S, Carlisle C, et al. Daytime hypertension in obstructive sleep apnea. Chest 1991; 99: 861-6.
51. Norton PG, Dunn EV. Snoring as a risk factor disease: an epidemiologic survey. Br Med J 1985; 291: 630-3.
52. Olson LG, King MT, Hensley MJ, et al. A community study of snoring and sleep disordered breathing. Am J Respir Crit Care Med 1995; 152: 711-6.
53. Schmidt-Nowara WW, Coultas D, Wiggins C, et al. Snoring in a Hispanic-American population: risk factors and association with hypertension and other morbidity. Arch Intern Med 1990; 150: 597-601.
54. Stradling JR, Crosby JH. Relation between systemic hypertension and sleep hypoxemia or snoring: analysis in 748 men drawn from general practice. Br Med J 1990; 300: 75-9.
55. Young T, Finn L, Hla KM, et al. Snoring as part of a dose-response relationship between sleep-disordered breathing and blood pressure. Sleep 1996; 19: S202-5.
56. Carlson JT, Hedner J, Ejnell H, Peterson LE. High prevalence hypertension in sleep apnea patients independent of obesity. Am J Respir Crit Care Med 1994; 150: 72-7.
57. Lavie P, Yoffe N, Berger I, Peled R. The relationship between the severity of sleep apnea syndrome and 24-h blood pressure in patients with obstructive sleep apnea. Chest 1993; 103: 717-21.
58. Kiselak J, Clark M, Pera V, et al. The association between hypertension and sleep apnea in obese patients. Chest 1993; 14: 775-80.
59. Kump K, Whalen C, Tishler PV, et al. Assessment of the utility and validity of a sleep symptom questionnaire in a community sample. Am J Respir Crit Care Med 1994; 150: 735-41.
60. Levinson PD, Millman RP. Causes and consequences of blood pressure alterations and obstructive sleep apnea. Arch Intern Med 1991; 151: 455-62.
61. Hu FB, Willett WC, Manson JE, et al. A prospective study of snoring and risk of hypertension and cardiovascular disease in women. Am J Epidemiol 1999; 150: 806-16.
62. Oparil S, Calhoun DA. Managing the patient with hard-to-control hypertension. Am Fam Physician 1998; 57: 5,1007-14, 1019-20.
63. Sleep Heart Health Study Research group. Sleep Heart Health Study Manual of Operations. Seattle, Wash; SHHS Coordinating Center, 1996.
64. Bradley TD, Brown JG, Grossman RF, et al. Pharyngeal size in snorers, nonsnorers, and patients with obstructive sleep apnea. N Engl J Med 1986; 315: 1327-31.
65. Hudgel DW. Mechanisms of obstructive sleep apnea. Chest 1992; 101: 541-9.
66. Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes. American Thoracic Society. Official statement adopted March, 1994. Am J Resp Crit Care Med 1994; 150: 1738-45.
67. Rapoport DM. Methods to stabilize the upper airway using positive pressure. Sleep 1996; 19 (9 suppl): 5123-30.
68. Guilleminault C, Stoohs R, Clerk A, et al. From obstructive sleep apnea syndrome to upper airways resistance syndrome: consistency of daytime sleepness. Sleep 1992; 15: S13-6.
69. Henderson II JH, Strollo PJ Jr. Medical management of obstructive sleep apnea. Prog Cardiov Dis 1999; 41: 377-86.
70. Hudgel DW, Thanakiycharu S. Pharmacologic treatment of sleep-disordered breathing. Am J Respir Crit Care Med 1998; 158: 691-9.
71. Rajagopal KR, Abbrecht PH, Derderian SS, et al. Obstructive sleep apnea in hypothyroidism. Ann Inter Med 1984; 101: 491-4.
72. Cartwright R, Stefosk ID, Caldarelli D, et al. Toward a treatment logic for sleep apnea: the place of the tongue retaining device. Behav Res Ther 1988; 26: 121-6.
73. Schmidt-Nowara WW, Lowe A, Wiggand L, et al. Oral appliances for the treatment of snoring and obstructive sleep apnea: a review. Sleep 1995; 18: 501-10.
74. Powell NB, Riley RW, Robinson A. Surgical management of obstructive sleep apnea syndrome. Clin Chest Med 1998; 19: 77-86.
75. Waradekar NV, Sinoway LI, Zwillich CW, et al. Influence of treatment on muscle sympathetic nerve activity in sleep apnea. Am J Respir Crit Care Med 1996; 153: 1333-8.
76. Lies A, Nabe B, Pankow W, Kohl FV, Lohmann FW. Hypertension and obstructive sleep apnea: ambulatory blood pressure monitoring before and with nCPAP-therapy. Z Kardiol 1996; 85(Suppl 3): 140-2.
77. Minemura H, Akashiba T, Yamamoto H, Akahoshi T, Kosaka N, Horie T. Acute effects of nasal continuous positive airway pressure on 24-hour blood presure and catecholamines in patients with obstructive sleep apnea. Intern Med 1998; 37: 1009-13.
78. Saarelainen S, Hasan J, Siitonen S, Seppälä E. Effect of nasal CPAP treatment on plasma volume, aldosterone and 24-h blood pressure in obstructive sleep apnoea. J Sleep Res 1996; 5: 181-5.
79. Dimsdale JE, Loredo JS, Profant J. Effect of continuous positive airway pressure on blood pressure: a placebo trial. Hypertension 2000; 35 (1 Pt1): 144-7.
80. Planès C, Foucher A, Leroy M, et al. Effect of celiprolol treatment in hypertensive patients with sleep apnea. Sleep 1999; 22: 507-13.
81. Grote L, Heitmann J, Köhler U, et al. Effect of angiotensin converting enzyme inhibition (cilazapril) on blood pressure recording in hypertensive obstructive sleep apneic patients. Blood Press 1997; 6: 235-41.
82. Kraiczi H, Hedner J, Peker Y, Grote L. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2000; 161: 1423-8.
83. Pelttari LH, Hietanen EK, Salo TT, Kataja MJ, Kantola IM. Little effect of ordinary antypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing. Am J Hypertens 1998; 11: 272-9.